245 related articles for article (PubMed ID: 25625803)
1. MEN1 mutations in Hürthle cell (oncocytic) thyroid carcinoma.
Kasaian K; Chindris AM; Wiseman SM; Mungall KL; Zeng T; Tse K; Schein JE; Rivera M; Necela BM; Kachergus JM; Casler JD; Mungall AJ; Moore RA; Marra MA; Copland JA; Thompson EA; Smallridge RC; Jones SJ
J Clin Endocrinol Metab; 2015 Apr; 100(4):E611-5. PubMed ID: 25625803
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
Máximo V; Soares P; Lima J; Cameselle-Teijeiro J; Sobrinho-Simões M
Am J Pathol; 2002 May; 160(5):1857-65. PubMed ID: 12000737
[TBL] [Abstract][Full Text] [Related]
3. The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions.
Chiappetta G; Toti P; Cetta F; Giuliano A; Pentimalli F; Amendola I; Lazzi S; Monaco M; Mazzuchelli L; Tosi P; Santoro M; Fusco A
J Clin Endocrinol Metab; 2002 Jan; 87(1):364-9. PubMed ID: 11788677
[TBL] [Abstract][Full Text] [Related]
4. Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridization.
Tallini G; Hsueh A; Liu S; Garcia-Rostan G; Speicher MR; Ward DC
Lab Invest; 1999 May; 79(5):547-55. PubMed ID: 10334566
[TBL] [Abstract][Full Text] [Related]
5. RET rearrangements in archival oxyphilic thyroid tumors: new insights in tumorigenesis and classification of Hürthle cell carcinomas?
Musholt PB; Imkamp F; von Wasielewski R; Schmid KW; Musholt TJ
Surgery; 2003 Dec; 134(6):881-9; discussion 889. PubMed ID: 14668719
[TBL] [Abstract][Full Text] [Related]
6. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy.
Ganly I; Ricarte Filho J; Eng S; Ghossein R; Morris LG; Liang Y; Socci N; Kannan K; Mo Q; Fagin JA; Chan TA
J Clin Endocrinol Metab; 2013 May; 98(5):E962-72. PubMed ID: 23543667
[TBL] [Abstract][Full Text] [Related]
7. Sporadic follicular thyroid tumors show loss of a 200-kb region in 11q13 without evidence for mutations in the MEN1 gene.
Nord B; Larsson C; Wong FK; Wallin G; Teh BT; Zedenius J
Genes Chromosomes Cancer; 1999 Sep; 26(1):35-9. PubMed ID: 10441003
[TBL] [Abstract][Full Text] [Related]
8. Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance.
Sobrinho-Simões M; Máximo V; Castro IV; Fonseca E; Soares P; Garcia-Rostan G; Oliveira MC
Int J Surg Pathol; 2005 Jan; 13(1):29-35. PubMed ID: 15735852
[TBL] [Abstract][Full Text] [Related]
9. [Multiple endocrine neoplasia: genetic aspects].
Calender A;
Bull Acad Natl Med; 2010 Jan; 194(1):81-95; discussion 95-6. PubMed ID: 20669561
[TBL] [Abstract][Full Text] [Related]
10. Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
Máximo V; Preto A; Crespo A; Rocha AS; Machado JC; Soares P; Sobrinho-Simões M
BMC Cancer; 2004 Mar; 4():12. PubMed ID: 15043758
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
12. A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors.
Evangelisti C; de Biase D; Kurelac I; Ceccarelli C; Prokisch H; Meitinger T; Caria P; Vanni R; Romeo G; Tallini G; Gasparre G; Bonora E
BMC Cancer; 2015 Mar; 15():157. PubMed ID: 25880213
[TBL] [Abstract][Full Text] [Related]
13. Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid.
Máximo V; Botelho T; Capela J; Soares P; Lima J; Taveira A; Amaro T; Barbosa AP; Preto A; Harach HR; Williams D; Sobrinho-Simões M
Br J Cancer; 2005 May; 92(10):1892-8. PubMed ID: 15841082
[TBL] [Abstract][Full Text] [Related]
14. Can abundant colloid exclude oncocytic (Hürthle cell) carcinoma in thyroid fine needle aspiration? Cytohistological correlation of 127 oncocytic (Hürthle cell) lesions.
Yang GC; Schreiner AM; Sun W
Cytopathology; 2013 Jun; 24(3):185-93. PubMed ID: 22672530
[TBL] [Abstract][Full Text] [Related]
15. PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma.
Wei S; LiVolsi VA; Montone KT; Morrissette JJ; Baloch ZW
Endocr Pathol; 2015 Dec; 26(4):365-9. PubMed ID: 26530486
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.
Hoos A; Stojadinovic A; Singh B; Dudas ME; Leung DH; Shaha AR; Shah JP; Brennan MF; Cordon-Cardo C; Ghossein R
Am J Pathol; 2002 Jan; 160(1):175-83. PubMed ID: 11786411
[TBL] [Abstract][Full Text] [Related]
17. Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid.
Hunt JL; Tometsko M; LiVolsi VA; Swalsky P; Finkelstein SD; Barnes EL
Am J Surg Pathol; 2003 Dec; 27(12):1559-64. PubMed ID: 14657716
[TBL] [Abstract][Full Text] [Related]
18. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1.
Loffler KA; Biondi CA; Gartside M; Waring P; Stark M; Serewko-Auret MM; Muller HK; Hayward NK; Kay GF
Int J Cancer; 2007 Jan; 120(2):259-67. PubMed ID: 17044021
[TBL] [Abstract][Full Text] [Related]
19. Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma: A Review and Multidisciplinary 2023 Update.
Bischoff LA; Ganly I; Fugazzola L; Buczek E; Faquin WC; Haugen BR; McIver B; McMullen CP; Newbold K; Rocke DJ; Russell MD; Ryder M; Sadow PM; Sherman E; Shindo M; Shonka DC; Singer MC; Stack BC; Wirth LJ; Wong RJ; Randolph GW
JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):265-272. PubMed ID: 38206595
[TBL] [Abstract][Full Text] [Related]
20. Near-haploidization significantly associates with oncocytic adrenocortical, thyroid, and parathyroid tumors but not with mitochondrial DNA mutations.
Corver WE; van Wezel T; Molenaar K; Schrumpf M; van den Akker B; van Eijk R; Ruano Neto D; Oosting J; Morreau H
Genes Chromosomes Cancer; 2014 Oct; 53(10):833-44. PubMed ID: 24909752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
